The class of companies all share a common goal of driving innovation in the health equity space, using technology across life sciences, to pharmaceuticals to champion equity, according to a July 20 press release. The four-month program will provide the founders with advice, mentoring and product development support. Some of the companies include a COVID-19 mobile testing unit for vulnerable populations and an AI-based diagnostics for remote patient monitoring.
“This cohort represents the type of patient-centered innovation we seek to support: early-stage companies driven by a mission to develop inclusive technologies and accelerate health equity within diverse populations,” said Jennifer McCaney, PhD, executive director of UCLA Biodesign. “We’re fortunate to be able to tap into the LA region’s rapidly growing tech ecosystem and its diverse talents, assets and infrastructure.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
